Shares of Uber Technologies (UBER - Free Report) are falling, hitting a new record low after its IPO lock-up period expired on Wednesday. The ride-hailing giant went public in May at $45 per share, but its value has taken a hit since then. UBER stock is down almost 40% since it IPO, and now trades at just under $27 per share.

What is an IPO lock-up period?

An IPO lock-up period places a restriction on insiders from selling shares of a company’s stock before it went public. The types of insiders include a company’s founders, owners, managers, and employees, and the waiting period typically ranges from 90 to 180 days.

Lock-up periods are either required by the underwriters, or imposed by the company that is going public. Investors who want to learn about a company’s lock-up period can find all the information in its S-1 filing with the SEC.

IPOs like Pinterest (PINS - Free Report) , Snap Inc. (SNAP - Free Report) , and Zoom Video (ZM - Free Report) all saw their share price impacted by the lock-up period expiration.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.5% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>